Research programme: antibody conjugated enzymes - Orum Therapeutics
Alternative Names: Antibody conjugated enzymes - Orum TherapeuticsLatest Information Update: 28 Aug 2023
At a glance
- Originator Orum Therapeutics
- Class Antibodies; Antineoplastics; Enzymes; Immunoconjugates; Immunotherapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer; Unspecified
Most Recent Events
- 28 Aug 2023 No recent reports of development identified for research development in Cancer in South Korea (Parenteral)
- 28 Aug 2023 No recent reports of development identified for research development in Unspecified in South Korea (Parenteral)
- 17 Jul 2019 Early research in Cancer in South Korea (Parenteral)